Search clinical trials for: Levonorgestrel IUD (LCS, BAY86-5028)

Total 126 results

Bayer

Completed

Dose-finding Study for the Ultralow-dose Levonorgestrel Intrauterine Contraceptive System (LCS)

Contraception

Sweden, Finland, Hungary, Norway, United Kingdom
Bayer

Completed

LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study

Contraception

Belgium, United States, Russian Federation, Germany, Austria
Bayer

Completed

GA Levonorgestrel Intrauterine Contraceptive System (LCS) Phase III Study China

Contraception

China, Korea, Republic of, Australia
Bayer

Completed

Bleeding Pattern Difference Between Levonorgestrel Intrauterine System (LNG-IUS) and Copper Intrauterine Devices (IUDs) Immediately Inserted After Abortion (POST)

Contraception

China
Bayer

Completed

Descriptive, Prospective, Non-interventional Study (NIS) to Describe Mirena and Amenorrhea Related Acceptability in Contraception Indication in Medical Practice (MARILIA)

Female Contraception

Algeria
Bayer

Completed

Prospective, Non-interventional, Multi-center Safety Study of Mirena for Heavy Menstrual Bleeding and Dysmenorrhea (J-MIRAI)

Menorrhagia, Dysmenorrhea

Japan
Bayer

Completed

Mirena in Idiopathic Menorrhagia

Idiopathic Menorrhagia

Croatia, Saudi Arabia, Bulgaria, Jordan, Romania, Russian Federation, Turkey, United Arab Emirates, Kuwait, India, Pakistan, Serbia, Sri Lanka
Bayer

Completed

Mirena Post-marketing Surveillance in Japan

Contraception

Japan
Bayer

Completed

Mirena Extension Trial (MET)

Contraception

United States
Bayer

Completed

Non-interventional Study of Long-term Intrauterine Contraceptives Acceptability and User Satisfaction (Mirabel)

Contraception

Russian Federation
Bayer

Completed

Acceptability of Long-term Progestin-only Contraception in Europe

Contraception

Slovakia, France, United Kingdom, Ireland
Bayer
University of Utah

Completed

Duration of Use of Highly Effective Reversible Contraception

Pregnancy

United States
Bayer

Completed

Cross -Over Study to Prove Bioequivalence Between Two Oral Formulations of Levonorgestrel (LEVEQ-2)

Contraception | Contraception, Postcoital

Mexico
Bayer

Completed

A Study to Compare 3 Doses of a Hormonal Intra-uterine Device Containing Levonorgestrel and Indomethacin With a Hormonal Intra-uterine Device Containing Only Levonorgestrel to Assess the Effect and Safety of the Combined Components (INDessa)

Contraception

Germany, United Kingdom
Bayer

Completed

Cross-over Study to Prove Bioequivalence Between Two Oral Formulations of Levonorgestrel (LEVEQ-1)

Contraception | Contraception, Postcoital

Mexico
Bayer

Completed

Survey on Patient Satisfaction Rate for Mirena Use in Heavy Menstrual Bleeding

Menorrhagia

Italy
Bayer

Completed

LCS12 Adolescent Study

Contraception

Belgium, Sweden, Austria, Finland, Netherlands, Germany, Denmark, Norway
Bayer

Completed

A Cross-sectional, Observational Multicenter Study to Assess the Reasons for Choosing the 3-year Hormonal IUD and Level of IUDs Knowledge Among Women Aged 18 to 29 Years (ANALIA)

Intrauterine Devices, Medicated

Spain
Bayer
Karolinska Institutet, Stockholm, Sweden

Active, not recruiting

JAYDESS Drug Utilization Study in Sweden

Contraception

Sweden
Bayer

Completed

An Observational Study to Assess Quality of Life and Satisfaction of Young Women (Aged 18-29) Following 6 (±1) Months Using Jaydess as Their Contraceptive Method (JULIA)

Quality of Life

Spain
Bayer

Completed

Mirena Observational Program

Endometrial Hyperplasia | Contraception | Menorrhagia | Estrogen Replacement Therapy

Kazakhstan
University of Utah

Completed

RAPID EC - Rct Assessing Pregnancy With Intrauterine Devices for EC

Contraception

United States
Bayer

Completed

Qlaira rPMS (Regulatory Post Marketing Surveillance) Study in Korea

Contraception

Korea, Republic of
Tulane University School of Medicine

Terminated

Patient Compliance With Long-Acting Reversible Contraception Administration

Contraception

United States
Bayer

Completed

Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)

Menorrhagia

United States, Canada, Brazil, Mexico, Argentina
Bayer

Completed

Cross-over Study to Prove Bioequivalence Between Two Oral Formulations of Levonorgestrel 1.5 mg (LEVEQ-3)

Contraceptives, Postcoital

Mexico
Bayer

Completed

Scandinavian Mirena Insertion Nulliparous Trial.

Nulliparous

Sweden
Oregon Health and Science University
Society of Family Planning

Terminated

Early Postpartum Intrauterine Device (IUD) Placement

Contraception

United States
Bayer

Completed

Wellnara Post-marketing Surveillance in Japan (WELLNARA)

Osteoporosis, Postmenopausal

Japan
Bayer

Completed

Zevalin Post-marketing Surveillance for Adequateness of Image Interpretation Criteria in Japan (ZEVALIN-SDUI)

Non-Hodgkin's Lymphoma (NHL)

Japan
Bayer

Completed

Mirena Efficiency and Tolerability During the First Year of Use

Contraception | Medicated Intrauterine Devices

France
Spectrum Pharmaceuticals, Inc
Bayer

Completed

Zevalin Post-marketing Surveillance in Japan (ZEVALIN-DUI)

Non-Hodgkin's Lymphoma (NHL)

Japan
Bayer

Completed

A Prospective Observational Study to Evaluate the Quality of Life and the Costs in a Real Life Setting in Patients Who Are Treated With 90Y-Zevalin

Lymphoma, Follicular | Non-Hodgkin Lymphoma

Belgium
Boston University
University of Utah

Completed

Insertion of an Intrauterine Device (IUD) After Medical Abortion

Medical Abortion | Induced Abortion | Intrauterine Device Expulsion

United States
Bayer

Completed

Mirena or Conventional Medical Treatment for Menorrhagia

Menorrhagia

China, Indonesia, Korea, Republic of, Malaysia, Thailand, Taiwan, Hong Kong, Pakistan
Sharon Achilles

Completed

Study of Immune Cell Changes in the Genital Tract 2 Months After Initiation of an IUD for Contraception (CHIC)

Genital Tract Mucosal Immunity | Genital Tract Microflora

United States
Bayer

Completed

Bleeding Pattern and User Satisfaction During Second Consecutive MIRENA® in Contraception and Treatment of Menorrhagia

Contraception | Menorrhagia

Finland, Ireland, France, Sweden
University of Utah

Completed

Study of the Copper IUD or Oral Levonorgestrel and the Levonorgestrel IUD for Women Seeking Emergency Contraception (COLIEC)

Emergency Contraception

United States
Bayer

Completed

MiCo - Mirena or Conventional Medical Treatment for Menorrhagia

Idiopathic Menorrhagia

Croatia, South Africa, Colombia, Czech Republic, Jordan, Lebanon, Macedonia, The Former Yugoslav Republic of, Moldova, Republic of, Romania, Ukraine, Venezuela, Bosnia and Herzegovina, Syrian Arab Republic, Albania
Mahidol University

Completed

The Effectiveness of Lng IUD for Treatment of the Patient Undergone Conservative Surgery for Pelvic Endometriosis

Endometriosis | Dysmenorrhea | Pelvic Pain

Thailand
Northwestern University
Society of Family Planning

Completed

Postpartum Glucose Tolerance With Levonorgesterel IUD Use in Women With Recent Gestational Diabetes

Glucose Intolerance | Type 2 Diabetes | Gestational Diabetes | Intrauterine Contraception

United States
University of Chicago

Terminated

Postplacental Insertion of Levonorgestrel-releasing Intrauterine System (LNG-IUS) After Cesarean vs. Interval Insertion

Healthy

United States
Bayer

Completed

LCS16 vs. COC User Satisfaction and Tolerability Study

Contraception

Russian Federation
University of Colorado, Denver
Society of Family Planning

Completed

Comparison of the Levonorgestrel IUD and the Copper IUD Placed in the Immediate Postplacental Period: A Prospective Cohort Study

Contraception

United States
University of Chicago
University of Illinois at Chicago

Completed

Maintaining Intrauterine Devices (IUDs) in Teens (MINT): A Randomization Trial (MINT)

Contraception

United States
Planned Parenthood of the St. Louis Region and...
University of Colorado, Denver; University of Rochester; Planned Parenthood Federation... and other collaborators

Completed

Levonorgestrel Intrauterine System For Emergency Contraception (LIFE)

Pregnancy, Unplanned | Pregnancy; Accident

United States
Bayer

Completed

Effects of Wellnara on Climacteric Symptoms

Postmenopause

Germany
Bayer

Completed

Treatment With [90]Y-Ibritumomab Tiuxetan Versus no Treatment in Patients With Follicular Non Hodgkin Lymphoma (Stage III or IV) Having Achieved a Partial or Complete Remission After First Line Chemotherapy

Lymphoma, Non-Hodgkin

Belgium, France, Spain, Italy, Canada, Switzerland, Netherlands, United Kingdom, Portugal, Germany, Sweden, Denmark, Norway
Bayer

Completed

Fat Distribution in Healthy Early Postmenopausal Women

Healthy | Postmenopause

Austria
Bayer

Completed

Study to Investigate Efficacy and Safety of a New Oral Contraceptive

Contraception

Germany, Austria, Spain

3

Subscribe